Fibromyalgia & musculoskeletal pain

Lower circulating IGF-1 levels in fibromyalgia: meta-analysis highlighting potential pathogenic role

Clin Exp RheumatolPublished Systematic review and meta-analysis

Pooled result · IGF-1 levelsResult — go to the resultSMD −0.347 95% CI −0.747 to 0.053

Authors' conclusion

Our meta-analysis demonstrated that IGF-1 levels were significantly lower in patients with FM

Study context

Population
Patients with fibromyalgia (FM) and healthy controls; serum/plasma IGF-1 levels12 studies from 11 reports
Participants
512 vs 308
Comparison
FM vs healthy controls
  • FMn = 512
  • Controlsn = 308reference
Outcome
Circulating (serum/plasma) IGF-1 levels
Methodological detailssubgroup analyses by region, sample size, data type, publication year and matched variables, sensitivity analysis, publication bias adjustment
  • Subgroup analyses by region, sample size, data type, publication year and matched variables
  • Sensitivity analysis
  • Publication bias adjustment

Pooled result

IGF-1 levels

SMD

−0.347

95% CI −0.747 to 0.053

P = 0.089

FMvs Controls
SMD −0.347 (95% CI −0.747 to 0.053); P = 0.089

As reported in the abstract

Further pooled results

OutcomeSMD (95% CI)P value
IGF-1 levels, studies with original data (subgroup)Significantly lower IGF-1 level in FM−0.458 (−0.857 to −0.060)P = 0.024
IGF-1 levels, recent publication year (year >2012) (subgroup)Significantly lower IGF-1 level in FM−0.679 (−1.066 to −0.293)P = 0.001

IGF-1 levels, sensitivity analysis (one study significantly affected the pooled SMD)

Pooled SMD after sensitivity analysis
SMD =−0.458, 95% CI: −0.822 to −0.093, p=0.014
  • Results of this meta-analysis were unstable

IGF-1 levels, adjusted for publication bias

SMD changed to be significant after adjusting for publication bias
SMD =−0.513, 95% CI: −0.924 to −0.102

Original publication

Lower circulating IGF-1 levels in fibromyalgia: meta-analysis highlighting potential pathogenic role. Clin Exp Rheumatol. Published 4 October 2024. doi:10.55563/clinexprheumatol/g17lb8

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.